Autres langues Moleculin Biotech, Inc.

Actions

MBRX

US60855D3098

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 23/04/2024			Varia. 5j.	Varia. 1 janv.
4,6 ^USD	+6,98 %		+7,48 %	-64,27 %

28/03	Transcript : Moleculin Biotech, Inc. - Special Call
27/03	Mise à jour sectorielle : Les actions du secteur de la santé progressent en fin d'après-midi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

European Medicines Agency Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia	19/04
Sector Update: Health Care Stocks Ease in Afternoon Trading	18/04
Moleculin Biotech Secures Orphan Drug Label For Annamycin in EU	18/04
European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)	18/04
Top Premarket Decliners	16/04
Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference	28/03
Moleculin to Participate in the Virtual Investor Lunch Break, the Moleculin Opportunity	28/03
Sector Update: Health Care Stocks Advance Late Afternoon	27/03
Sector Update: Health Care	27/03
Moleculin Biotech Shares Rise Following Patent Announcement	27/03
Moleculin to Participate in the Virtual Investor Lunch Break: The Moleculin Opportunity	27/03
Moleculin Announces U.S. Patent Issue Notification for Annamycin Targeting Unmet Need in AML	27/03
Moleculin Reports Full Year 2023 Financial Results	25/03
Moleculin Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial	25/03
Moleculin Biotech, Inc Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial	25/03
Moleculin Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
Moleculin to Report Full Year 2023 Financial Results on March 22, 2024 and Host Conference Call and Webcast	20/03
North American Morning Briefing : Markets on Hold as Fed Decision Nears	20/03
Moleculin Biotech to Effect 1-For-15 Reverse Stock Split to Regain Compliance	19/03
Moleculin Announces Reverse Stock Split	19/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Moleculin Biotech, Inc.

Actions

MBRX

US60855D3098

Autres langues

Filtres